Results 21 to 30 of about 3,101,103 (310)

The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas

open access: yesFrontiers in Endocrinology, 2021
Human pituitary adenomas are one of the most common intracranial neoplasms. Although most of these tumors are benign and can be treated medically or by transsphenoidal surgery, a subset of these tumors are fast-growing, aggressive, recur, and remain a ...
Zhiyu Xi   +10 more
doaj   +1 more source

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1

open access: yesFrontiers in Endocrinology, 2023
Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj   +1 more source

Pituitary blastoma, expanding the spectrum of newly recognized entities. A case report

open access: yesIndian Journal of Pathology and Microbiology, 2022
Tumors of the pituitary gland and sellar region represent about 15% of all brain tumors, with pituitary adenoma being the commonest and pituitary carcinoma being very rare. Pituitary tumors in children are even rarer.
Meenakshi Swain   +2 more
doaj   +1 more source

Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

open access: yesBMC Endocrine Disorders, 2020
Background Pituitary adenomas as multifactorial intracranial neoplasms impose a massive burden of morbidity on patients and characterizing the molecular mechanism underlying their pathogenesis has received considerable attention.
Nasrin Akbari   +9 more
doaj   +1 more source

Coexistence of Pituitary Adenoma and Primary Pituitary Lymphoma: A Case Report and Review of the Literature

open access: yesFrontiers in Surgery, 2022
In the pituitary sella, the coexistence of pituitary adenoma and primary pituitary lymphoma is exceedingly rare. Thus far, only six cases have been reported. Here, we present the seventh case of coexisting pituitary adenoma and primary pituitary lymphoma,
Shangjun Ren   +6 more
doaj   +1 more source

The epidemiology of aggressive pituitary tumors (and its challenges)

open access: yesReviews in Endocrine & Metabolic Disorders, 2020
Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are considered; approximately 0.5% of all pituitary adenomas will come to medical attention.
O. Dekkers, N. Karavitaki, A. Pereira
semanticscholar   +1 more source

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

open access: yesJournal of Clinical Endocrinology and Metabolism, 2020
Context Aggressive pituitary tumors (APTs) are characterized by unusually rapid growth and lack of response to standard treatment. About 1% to 2% develop metastases being classified as pituitary carcinomas (PCs).
O. Casar-Borota   +28 more
semanticscholar   +1 more source

Evaluation and Current Clinical Progress of Invasiveness in Postoperative Residual Regrowth and Recurrence of Pituitary Adenoma

open access: yesZhongliu Fangzhi Yanjiu, 2022
Pituitary adenoma is one common type of intracranial tumors, accounting for about 10% of intracranial tumors. Although pituitary adenomas are benign tumors, the complete resection and recurrence prevention remain challengeable due to aggressive growth of
LEI Ting   +5 more
doaj   +1 more source

Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?

open access: yesEndocrine Oncology, 2023
Pituitary adenomas are benign neoplasms of the pituitary. The most prevalent are prolactinomas and non-functioning pituitary adenomas, followed by growth hormone-and ACTH-secreting adenomas.
Sandra Pekic   +2 more
doaj   +1 more source

The 2017 WHO classification and International Classification of Disease coding analysis of non⁃neuroendocrine tumors in the pituitary gland

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
The fourth edition of the latest classification principles for endocrine tumors was published by the World Health Organization (WHO) in 2017. The latest tumor classification and new pathological classification of each pituitary gland tumor were given in ...
GUAN Hong   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy